B. Riley Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,800
Closed -$96K 426
2019
Q3
$96K Sell
16,800
-500
-3% -$3.4K 0.02% 371
2019
Q2
$133 Buy
17,300
+2,500
+17% +$13.5K 0.02% 371
2019
Q1
$78K Buy
+14,800
New +$103K 0.01% 384
2016
Q1
Sell
-10,695
Closed -$319K 158
2015
Q4
$319K Buy
10,695
+3,430
+47% +$116K 0.41% 87
2015
Q3
$228K Sell
7,265
-303
-4% -$14.8K 0.32% 128
2015
Q2
$366K Buy
7,568
+3,487
+85% +$147K 0.29% 87
2015
Q1
$176K Buy
+4,081
New +$147K 0.13% 215

Other funds holding PGEN

B. Riley Wealth Management's PGEN Position: Q4 2019 in Review

B. Riley Wealth Management sold out of Precigen (PGEN) in Q4 2019, closing a stake of 16,800 shares — an estimated $96K sold.

B. Riley Wealth Management first reported a position in PGEN in Q1 2015 and held it in 7 quarters. The position peaked at $366K in Q2 2015. 167 funds tracked by Wall St. Rank hold PGEN as of Q4 2019.

  • B. Riley Wealth Management reported no remaining Precigen position as of Q4 2019 after selling out during the quarter.
  • B. Riley Wealth Management sold 16,800 Precigen shares in Q4 2019, an estimated $96K.
  • B. Riley Wealth Management first reported a position in Precigen in Q1 2015 and held it in 7 quarters.
  • B. Riley Wealth Management's Precigen position peaked at $366K in Q2 2015.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q4 2019.

Based on B. Riley Wealth Management's 13F filing for Q4 2019, filed 14 Feb 2020.